NAM
Needelman Asset Management Portfolio holdings
AUM
$46M
1-Year Est. Return
8.27%
1 Year Est. Return
+8.27%
AUM
$46.4M
AUM Growth
+$6.38M
(+16%)
Holding
37
Top Buys
| 1 | +$2.62M | |
| 2 | +$1.77M | |
| 3 | +$1.65M | |
| 4 |
AT&T
T
|
+$1.05M |
| 5 |
Gilead Sciences
GILD
|
+$525K |
Top Sells
| 1 | +$926K | |
| 2 | +$728K | |
| 3 | +$456K | |
| 4 |
Microsoft
MSFT
|
+$38.3K |
| 5 |
Bank of America
BAC
|
+$34.8K |
Sector Composition
| 1 | Financials | 25.31% |
| 2 | Healthcare | 22.13% |
| 3 | Technology | 17.54% |
| 4 | Consumer Staples | 10.64% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wells Fargo
WFC
$270B
| $3.34M | 7.2% |
63,696
+49,970
|
|
||
|
2
AT&T
T
$175B
| $1.93M | 4.16% |
71,642
+39,065
|
|
||
3
IBM
IBM
$292B
| $1.92M | 4.13% |
13,060
+11,234
|
|
||
4
Rio Tinto
RIO
$113B
| $1.77M | 3.83% |
+34,440
|
|
||
5
Fluor
FLR
$7.21B
| $1.67M | 3.6% |
29,180
+8,065
|
|
||
|
6
Gilead Sciences
GILD
$153B
| $1.67M | 3.6% |
22,130
+6,965
|
|
||
|
7
Microsoft
MSFT
$3.69T
| $1.64M | 3.54% |
17,965
-420
|
|
||
|
8
Bank of America
BAC
$389B
| $1.63M | 3.51% |
54,336
-1,160
|
|
||
9
JPMorgan Chase
JPM
$853B
| $1.61M | 3.47% |
14,618
-300
|
|
||
10
Intel
INTC
$178B
| $1.6M | 3.44% |
30,661
+41
|
|
||
11
Markel Group
MKL
$25.3B
| $1.52M | 3.28% |
1,300
-10
|
|
||
12
Berkshire Hathaway Class B
BRK.B
$1.06T
| $1.49M | 3.21% |
7,460
-145
|
|
||
13
Honeywell
HON
$124B
| $1.4M | 3.01% |
10,080
-125
|
|
||
14
Elevance Health
ELV
$69.9B
| $1.36M | 2.94% |
6,215
-30
|
|
||
15
UnitedHealth
UNH
$291B
| $1.34M | 2.9% |
6,282
-35
|
|
||
16
AbbVie
ABBV
$387B
| $1.33M | 2.88% |
14,092
+4,070
|
|
||
17
Kimberly-Clark
KMB
$33.4B
| $1.33M | 2.87% |
12,083
+4,510
|
|
||
18
Johnson & Johnson
JNJ
$450B
| $1.32M | 2.85% |
10,310
+540
|
|
||
19
Abbott
ABT
$217B
| $1.27M | 2.73% |
21,132
-135
|
|
||
20
Diageo
DEO
$48.5B
| $1.24M | 2.68% |
9,182
-45
|
|
||
21
Emerson Electric
EMR
$74B
| $1.21M | 2.61% |
17,735
-105
|
|
||
22
Chevron
CVX
$306B
| $1.15M | 2.47% |
10,040
-75
|
|
||
23
Chubb
CB
$111B
| $1.1M | 2.38% |
8,055
-56
|
|
||
24
Pfizer
PFE
$141B
| $1.08M | 2.33% |
32,057
+195
|
|
||
25
Aon
AON
$73.1B
| $1.06M | 2.28% |
7,525
|
|